Nav1.8 inhibitor – Talk Bio

Actionable Insights Powered by AI

Eli Lilly Acquires SiteOne for Up to $1B to Expand Non-Opioid Pain Pipeline

2 weeks ago talkbio0Tagged Acquisition, Chronic pain, Drug Industry, eli lilly, Nav1.8 inhibitor, neuroscience pipeline, non-opioid pain treatment, SiteOne Therapeutics, STC-004

Eli Lilly; SiteOne Therapeutics; non-opioid pain treatment; STC-004; acquisition; Nav1.8 inhibitor; chronic pain; neuroscience pipeline; Vertex; pharmaceutical industry